{"title":"Treatment of Pelvic Floor Hypertonic Disorders with top Flat Magnetic Stimulation in Women with Vestibulodynia: A Pilot Study","authors":"A. Biondo, F. Murina, I. Fusco","doi":"10.26502/fjwhd.2644-28840087","DOIUrl":null,"url":null,"abstract":"Background: Vulvodynia is a popular disease that affects around the 15% of women. Objectives: In this study we assess the effectiveness and the safeness of a new device that uses Top Flat Magnetic Stimulation for the management of the hypertone in women with vulvodynia. Methods: PISQ-12 questionnaire for sexual function was used for the evaluation of patient’s vulvodynia improvements. Possible side effects were examined. Results: In all women examined, the mean score of PISQ-12 significantly decrease from 27,4 (SD 9.6) before treatment session to 15,5 (SD 7.9) after the last session (p < .001), showing an improvement in vulvodynia symptoms. No Side effects were observed. Conclusion: On the basis of our findings this new technology seems to be able to effectively treat the hypertone condition in vulvodynia disease.","PeriodicalId":74017,"journal":{"name":"Journal of women's health and development","volume":"41 1","pages":""},"PeriodicalIF":0.0000,"publicationDate":"2022-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"3","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Journal of women's health and development","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.26502/fjwhd.2644-28840087","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"","JCRName":"","Score":null,"Total":0}
引用次数: 3
Abstract
Background: Vulvodynia is a popular disease that affects around the 15% of women. Objectives: In this study we assess the effectiveness and the safeness of a new device that uses Top Flat Magnetic Stimulation for the management of the hypertone in women with vulvodynia. Methods: PISQ-12 questionnaire for sexual function was used for the evaluation of patient’s vulvodynia improvements. Possible side effects were examined. Results: In all women examined, the mean score of PISQ-12 significantly decrease from 27,4 (SD 9.6) before treatment session to 15,5 (SD 7.9) after the last session (p < .001), showing an improvement in vulvodynia symptoms. No Side effects were observed. Conclusion: On the basis of our findings this new technology seems to be able to effectively treat the hypertone condition in vulvodynia disease.